Review



kg1a set 2  (DSMZ)


Bioz Verified Symbol DSMZ is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    DSMZ kg1a set 2
    Kg1a Set 2, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 116 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kg1a/bio_rxiv__64898__2025__12__11__691106-29-26-31?v=DSMZ
    Average 94 stars, based on 116 article reviews
    kg1a set 2 - by Bioz Stars, 2026-07
    94/100 stars

    Images



    Similar Products

    kg1a  (ATCC)
    96
    ATCC kg1a
    Kg1a, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kg1a/pm41692271-56-15-16?v=ATCC
    Average 96 stars, based on 1 article reviews
    kg1a - by Bioz Stars, 2026-07
    96/100 stars
    		  Buy from Supplier
    kg1a  (Pasteur Institute)
    86
    Pasteur Institute kg1a
    Kg1a, supplied by Pasteur Institute, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kg1a/pm42270693-35-6-19?v=Pasteur+Institute
    Average 86 stars, based on 1 article reviews
    kg1a - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    kg1a set 2  (DSMZ)
    94
    DSMZ kg1a set 2
    Kg1a Set 2, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kg1a/bio_rxiv__64898__2025__12__11__691106-29-26-31?v=DSMZ
    Average 94 stars, based on 1 article reviews
    kg1a set 2 - by Bioz Stars, 2026-07
    94/100 stars
    		  Buy from Supplier
    human leukemia cell line kg1a  (ATCC)
    96
    ATCC human leukemia cell line kg1a
    Human Leukemia Cell Line Kg1a, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kg1a/pmc12701985-137-0-10?v=ATCC
    Average 96 stars, based on 1 article reviews
    human leukemia cell line kg1a - by Bioz Stars, 2026-07
    96/100 stars
    		  Buy from Supplier
    kg1a cell lines  (ATCC)
    96
    ATCC kg1a cell lines
    NOV340 liposomes deliver RNA into AML cells in vitro via macropinocytosis (A) Graphic of Cy3-MTL-CEBPA and controls. (B) Delivery of fluorescently tagged CEBPA-51 saRNA in myeloid leukemia and lymphoid leukemia cell lines. Two-way ANOVA with Holm-Sidak multiple comparison test; n = 3. Data represented as mean (SD). (C) Schematic of endocytosis inhibitors used for in vitro uptake inhibition assay. (D) Representative histograms of Cy3 fluorescence in AML cell lines after treatment with clathrin-mediated endocytosis inhibitor, Pitstop 2, or macropinocytosis inhibitors, EIPA or imipramine. (E) Changes in uptake of Cy3-MTL-CEBPA following treatment with endocytosis inhibitors in THP-1, MOLM-14, and <t>KG1a</t> cells. Two-way ANOVA with Holm-Sidak multiple comparison test; n = 3. Data represented as mean (SD).
    Kg1a Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/kg1a/pmc12271619-222-4-11?v=ATCC
    Average 96 stars, based on 1 article reviews
    kg1a cell lines - by Bioz Stars, 2026-07
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    NOV340 liposomes deliver RNA into AML cells in vitro via macropinocytosis (A) Graphic of Cy3-MTL-CEBPA and controls. (B) Delivery of fluorescently tagged CEBPA-51 saRNA in myeloid leukemia and lymphoid leukemia cell lines. Two-way ANOVA with Holm-Sidak multiple comparison test; n = 3. Data represented as mean (SD). (C) Schematic of endocytosis inhibitors used for in vitro uptake inhibition assay. (D) Representative histograms of Cy3 fluorescence in AML cell lines after treatment with clathrin-mediated endocytosis inhibitor, Pitstop 2, or macropinocytosis inhibitors, EIPA or imipramine. (E) Changes in uptake of Cy3-MTL-CEBPA following treatment with endocytosis inhibitors in THP-1, MOLM-14, and KG1a cells. Two-way ANOVA with Holm-Sidak multiple comparison test; n = 3. Data represented as mean (SD).

    Journal: Molecular Therapy. Nucleic Acids

    Article Title: RNA activation of CEBPA improves leukemia treatment

    doi: 10.1016/j.omtn.2025.102611

    Figure Lengend Snippet: NOV340 liposomes deliver RNA into AML cells in vitro via macropinocytosis (A) Graphic of Cy3-MTL-CEBPA and controls. (B) Delivery of fluorescently tagged CEBPA-51 saRNA in myeloid leukemia and lymphoid leukemia cell lines. Two-way ANOVA with Holm-Sidak multiple comparison test; n = 3. Data represented as mean (SD). (C) Schematic of endocytosis inhibitors used for in vitro uptake inhibition assay. (D) Representative histograms of Cy3 fluorescence in AML cell lines after treatment with clathrin-mediated endocytosis inhibitor, Pitstop 2, or macropinocytosis inhibitors, EIPA or imipramine. (E) Changes in uptake of Cy3-MTL-CEBPA following treatment with endocytosis inhibitors in THP-1, MOLM-14, and KG1a cells. Two-way ANOVA with Holm-Sidak multiple comparison test; n = 3. Data represented as mean (SD).

    Article Snippet: THP-1, HL-60, K562, and KG1a cell lines were obtained from the American Type Culture Collection (ATCC).

    Techniques: Liposomes, In Vitro, Comparison, Inhibition, Fluorescence

    MTL-CEBPA upregulates CEBPA in AML in vitro models (A) Changes in CEBPA mRNA expression in THP-1, KG1a, or MOLM-14 cell lines 72-h post-MTL-CEBPA or control (MTL-FLUC) treatment. Two-tailed unpaired student t tests; n = 3. Data represented as mean (SD). (B) Representative western blots of THP-1 and MOLM-14 cell lines 96 h post-treatment. (C) Upregulation of CEBPA mRNA in ex vivo AML3 patient sample 48 h post MTL-CEBPA or control (MTL-FLUC) treatment. Two-tailed unpaired student t test; n = 3. Data represented as mean (SD).

    Journal: Molecular Therapy. Nucleic Acids

    Article Title: RNA activation of CEBPA improves leukemia treatment

    doi: 10.1016/j.omtn.2025.102611

    Figure Lengend Snippet: MTL-CEBPA upregulates CEBPA in AML in vitro models (A) Changes in CEBPA mRNA expression in THP-1, KG1a, or MOLM-14 cell lines 72-h post-MTL-CEBPA or control (MTL-FLUC) treatment. Two-tailed unpaired student t tests; n = 3. Data represented as mean (SD). (B) Representative western blots of THP-1 and MOLM-14 cell lines 96 h post-treatment. (C) Upregulation of CEBPA mRNA in ex vivo AML3 patient sample 48 h post MTL-CEBPA or control (MTL-FLUC) treatment. Two-tailed unpaired student t test; n = 3. Data represented as mean (SD).

    Article Snippet: THP-1, HL-60, K562, and KG1a cell lines were obtained from the American Type Culture Collection (ATCC).

    Techniques: In Vitro, Expressing, Control, Two Tailed Test, Western Blot, Ex Vivo